Discover 3,012 paid clinical trials in Riverside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,012
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
for
Advanced Alveolar Soft Part Sarcoma,
Location: Los Angeles CA, Oklahoma City OK, Houston TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05333458
Phase 2, Recruiting
Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma
for
Advanced NUT Carcinoma, Metastatic NUT Carcinoma,
Location: Los Angeles CA, Houston TX, Pittsburgh PA, Boston MA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05019716
Phase 1, Phase 2, Recruiting
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Los Angeles CA, La Jolla CA, Salt Lake City UT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05896839
Phase 1, Phase 2, Recruiting
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
for
Advanced Melanoma
Location: Los Angeles CA, Santa Monica CA, La Jolla CA, Tucson AZ,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT06112314
Phase 3, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Los Angeles CA, Vancouver, Toronto, Hackensack NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06476808
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Access to Genetic Testing in Underserved Patients With Cancer
for
Breast Carcinoma, Male Breast Carcinoma,
Location: Los Angeles CA, Rochester NY
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06422455
Recruiting
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
for
Prostate Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Male
Age: 18+
Code: NCT06067295
Recruiting
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
for
Advanced Solid Tumors Cancer, MSI-H Cancer
Location: Los Angeles CA, Chicago IL, Louisville KY, Maumee OH,
Sponsor: Nimbus Wadjet, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06898450
Phase 1, Phase 2, Recruiting
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
for
Head and Neck Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT06420219
Recruiting
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
for
Triple Negative Locally Advanced Non-resectable Breast Cancer,
Location: Los Angeles CA, Vancouver, San Antonio TX, Nashville TN,
Sponsor: Marengo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06827613
Phase 1, Phase 2, Recruiting
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Location: Los Angeles CA, Stanford CA, Houston TX, Louisville KY,
Sponsor: Obsidian Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06060613
Phase 1, Phase 2, Recruiting
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
for
Extensive-stage Small-cell Lung Cancer
Location: Los Angeles CA, Lexington KY, Atlanta GA, Rock Hill SC,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07459634
Phase 2, Recruiting
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
for
Breast, Metastatic, Triple Negative, Cancer,
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18 - 70+
Code: NCT04333706
Phase 1, Phase 2, Recruiting
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
for
Extensive Stage Small Cell Lung Cancer
Location: Los Angeles CA, Seattle WA, Sioux Falls SD, Houston TX,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT06598306
Phase 1, Recruiting
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Los Angeles CA, Aurora CO, Columbus OH, Orlando FL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06233942
Phase 1, Recruiting
Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas
for
Peripheral T-cell Lymphoma
Location: Los Angeles CA, Gilbert AZ, Dallas TX, Westwood KS,